Compound ID | 249
Class: Bacterial topoisomerase inhibitor
| Spectrum of activity: | Gram-negative |
| Details of activity: | Staphylococcus aureus Streptococcus pneumoniae, enterococci and Clostridium difficile |
| Institute where first reported: | Biota Europe Ltd., UK |
| Year first mentioned: | 2013 |
| Highest developmental phase: | Preclinical |
| Development status: | Active |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| Citations: |
|